Supplementary Table S4 from A Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy

Junji Furuse,Masafumi Ikeda,Makoto Ueno,Masayuki Furukawa,Chigusa Morizane,Tetsuo Takehara,Tomohiro Nishina,Akiko Todaka,Naohiro Okano,Kazuo Hara,Yousuke Nakai,Kazuyoshi Ohkawa,Takashi Sasaki,Kazuya Sugimori,Naoyuki Yokoyama,Kouji Yamamoto

crossref（2024）

引用 0|浏览0

暂无评分

摘要

Supplementary Table S4. Adverse events occurring in patients with BTC, shown by “All grades.”.

更多

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要